STERIS plc (STE) - Total Assets

Latest as of December 2025: $10.59 Billion USD

Based on the latest financial reports, STERIS plc (STE) holds total assets worth $10.59 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of STERIS plc for net asset value and shareholders' equity analysis.

STERIS plc - Total Assets Trend (1991–2025)

This chart illustrates how STERIS plc's total assets have evolved over time, based on quarterly financial data.

STERIS plc - Asset Composition Analysis

Current Asset Composition (March 2025)

STERIS plc's total assets of $10.59 Billion consist of 19.7% current assets and 80.3% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $171.70 Million 1.7%
Accounts Receivable $1.04 Billion 10.3%
Inventory $581.33 Million 5.7%
Property, Plant & Equipment $2.11 Billion 20.8%
Intangible Assets $1.85 Billion 18.3%
Goodwill $4.10 Billion 40.4%

Asset Composition Trend (1991–2025)

This chart illustrates how STERIS plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see STERIS plc (STE) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: STERIS plc's current assets represent 19.7% of total assets in 2025, a decrease from 81.8% in 1991.
  • Cash Position: Cash and equivalents constituted 1.7% of total assets in 2025, down from 6.8% in 1991.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, an increase from 6.0% in 1991.
  • Asset Diversification: The largest asset category is goodwill at 40.4% of total assets.

STERIS plc Competitors by Total Assets

Key competitors of STERIS plc based on total assets are shown below.

Company Country Total Assets
Jafron Biomedical Co Ltd
SHE:300529
China CN¥5.54 Billion
Sinocare Inc
SHE:300298
China CN¥6.25 Billion
Shanghai Kinetic Medical Co
SHE:300326
China CN¥3.38 Billion
Eurobio Scientific SA
PA:ALERS
France €259.11 Million
EBR Systems Inc
AU:EBR
Australia AU$97.29 Million
PULSION Medical Systems SE
MU:PUS
Germany €35.15 Million
Aroa Biosurgery Ltd
AU:ARX
Australia AU$95.27 Million
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
China CN¥805.10 Million

STERIS plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.48 2.13 2.10
Quick Ratio 1.75 1.40 1.55
Cash Ratio 0.46 0.17 0.00
Working Capital $1.36 Billion $1.01 Billion $633.83 Million

STERIS plc - Advanced Valuation Insights

This section examines the relationship between STERIS plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.02
Latest Market Cap to Assets Ratio 2.07
Asset Growth Rate (YoY) -8.3%
Total Assets $10.15 Billion
Market Capitalization $21.03 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values STERIS plc's assets at a significant premium (2.07x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: STERIS plc's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for STERIS plc (1991–2025)

The table below shows the annual total assets of STERIS plc from 1991 to 2025.

Year Total Assets Change
2025-03-31 $10.15 Billion -8.29%
2024-03-31 $11.06 Billion +2.23%
2023-03-31 $10.82 Billion -5.27%
2022-03-31 $11.42 Billion +73.76%
2021-03-31 $6.57 Billion +21.18%
2020-03-31 $5.43 Billion +6.95%
2019-03-31 $5.07 Billion -2.45%
2018-03-31 $5.20 Billion +5.60%
2017-03-31 $4.92 Billion -7.89%
2016-03-31 $5.35 Billion +154.66%
2015-03-31 $2.10 Billion +11.25%
2014-03-31 $1.89 Billion +7.16%
2013-03-31 $1.76 Billion +25.28%
2012-03-31 $1.41 Billion -1.47%
2011-03-31 $1.43 Billion +15.20%
2010-03-31 $1.24 Billion +1.76%
2009-03-31 $1.22 Billion -1.80%
2008-03-31 $1.24 Billion +2.49%
2007-03-31 $1.21 Billion +1.70%
2006-03-31 $1.19 Billion +0.27%
2005-03-31 $1.19 Billion +11.00%
2004-03-31 $1.07 Billion +19.35%
2003-03-31 $894.99 Million +6.35%
2002-03-31 $841.57 Million -0.40%
2001-03-31 $844.98 Million -6.48%
2000-03-31 $903.57 Million +4.34%
1999-03-31 $866.00 Million +18.25%
1998-03-31 $732.33 Million +35.74%
1997-03-31 $539.50 Million -8.98%
1996-03-31 $592.70 Million +979.60%
1995-03-31 $54.90 Million +28.57%
1994-03-31 $42.70 Million +38.19%
1993-03-31 $30.90 Million +286.25%
1992-03-31 $8.00 Million +81.82%
1991-03-31 $4.40 Million --

About STERIS plc

NYSE:STE USA Medical Devices
Market Cap
$21.03 Billion
Market Cap Rank
#1235 Global
#492 in USA
Share Price
$214.46
Change (1 day)
+0.70%
52-Week Range
$212.25 - $268.65
All Time High
$268.65
About

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more